Bicocca Open Archive

Logo unimib boa
ALBERTI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.114
AS - Asia 15.323
EU - Europa 9.628
SA - Sud America 1.602
AF - Africa 193
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 15
Totale 45.922
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.671
VN - Vietnam 5.094
SG - Singapore 4.374
CN - Cina 2.706
IT - Italia 2.219
HK - Hong Kong 1.767
RU - Federazione Russa 1.619
DE - Germania 1.500
BR - Brasile 1.304
SE - Svezia 1.102
IE - Irlanda 883
GB - Regno Unito 520
UA - Ucraina 387
CA - Canada 297
IN - India 274
FI - Finlandia 232
KR - Corea 232
FR - Francia 210
TR - Turchia 155
AT - Austria 154
JP - Giappone 154
ID - Indonesia 149
LT - Lituania 132
AR - Argentina 124
NL - Olanda 120
DK - Danimarca 119
ES - Italia 108
MX - Messico 98
BD - Bangladesh 91
ZA - Sudafrica 82
PL - Polonia 69
BE - Belgio 60
EC - Ecuador 53
IQ - Iraq 53
AU - Australia 42
PK - Pakistan 41
CH - Svizzera 40
CO - Colombia 35
SA - Arabia Saudita 29
GR - Grecia 27
TW - Taiwan 26
UZ - Uzbekistan 25
VE - Venezuela 22
MA - Marocco 21
IL - Israele 20
PY - Paraguay 20
EG - Egitto 19
RO - Romania 18
IR - Iran 16
PT - Portogallo 16
MY - Malesia 15
PE - Perù 15
KZ - Kazakistan 14
TN - Tunisia 14
BG - Bulgaria 13
CZ - Repubblica Ceca 13
EU - Europa 13
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
JO - Giordania 11
KE - Kenya 11
CL - Cile 10
TH - Thailandia 10
AZ - Azerbaigian 9
CR - Costa Rica 9
HR - Croazia 9
LV - Lettonia 9
DZ - Algeria 8
ET - Etiopia 8
HU - Ungheria 8
AL - Albania 7
BH - Bahrain 7
GT - Guatemala 7
JM - Giamaica 7
NG - Nigeria 7
NO - Norvegia 7
PA - Panama 7
PH - Filippine 7
AO - Angola 6
BO - Bolivia 6
NP - Nepal 6
SI - Slovenia 6
BN - Brunei Darussalam 5
HN - Honduras 5
SC - Seychelles 5
DO - Repubblica Dominicana 4
LU - Lussemburgo 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
OM - Oman 4
PS - Palestinian Territory 4
RS - Serbia 4
NI - Nicaragua 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
IS - Islanda 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
Totale 45.894
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.158
Dallas 2.676
Singapore 2.552
Hong Kong 1.755
Ho Chi Minh City 1.560
Ashburn 1.478
Hanoi 1.257
Fairfield 860
Dublin 857
Milan 834
Woodbridge 831
Wilmington 792
Frankfurt am Main 733
Chandler 718
Houston 569
Dearborn 505
New York 490
Santa Clara 482
Hefei 392
Seattle 378
Beijing 373
Jacksonville 367
Los Angeles 356
Princeton 330
Cambridge 293
Nanjing 211
Munich 192
Seoul 178
Shanghai 154
The Dalles 153
Haiphong 152
Moscow 150
Chicago 147
Da Nang 145
São Paulo 143
Guangzhou 141
Buffalo 137
Boardman 136
Ha Long 130
Vienna 119
Vilnius 115
Jakarta 112
Quận Bình Thạnh 107
Helsinki 98
Biên Hòa 96
Hải Dương 95
Lawrence 94
Tokyo 79
Ninh Bình 78
Rome 78
Thái Nguyên 78
Altamura 77
London 74
Vũng Tàu 74
Can Tho 72
Dong Ket 69
Bắc Ninh 67
Toronto 67
Denver 61
Council Bluffs 59
Nuremberg 58
Quận Một 58
Shenyang 58
Montreal 57
Lachine 55
Nanchang 55
San Diego 53
Stockholm 53
Warsaw 53
Andover 52
Phoenix 52
Poplar 52
Tianjin 50
Bắc Giang 49
Atlanta 48
Changsha 48
Hangzhou 47
Rio de Janeiro 47
Brooklyn 45
Carate Brianza 45
Kent 45
Chennai 43
Brussels 40
Hebei 40
Jinan 39
Orem 39
Vinh 39
Mexico City 38
Pune 38
Phủ Lý 37
Amsterdam 36
Boston 36
Quận Phú Nhuận 36
Turku 36
Ottawa 35
Quận Sáu 35
Turin 35
Johannesburg 33
Mountain View 32
Quận Bảy 32
Totale 30.313
Salva come PNG Salva come JPEG
Nome #
Oxaliplatin-induced Alteration of Sodium-Calcium Exchanger as a Pivotal Element Leading to Peripheral Neurotoxicity and Necroptosis 696
SODIUM-CALCIUM EXCHANGER PIVOTAL ROLE IN OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY, AXONAL DAMAGE AND NECROPTOSIS 579
High-Resolution MRI for Peripheral Nervous System Imaging: Volumetric Rendering in Rodent Models 548
Sodium-Calcium Exchanger 2 Role In An In Vitro Oxaliplatin-Induced Peripheral Neurotoxicity Model 531
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 507
Translational Approach to Oxaliplatin Induced Peripheral Neurotoxicity - Neurophysiology: the Link between Bed and Bench "side" 456
In vitro neurotoxicity testing: lessons from chemotherapy-induced peripheral neurotoxicity 448
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 446
A PILOT STUDY ON HEALTH-ECONOMICS BURDEN DUE TO CHEMOTHERAPY-INDUCED NEUROTOXICITY 445
Nelarabine-Induced Neurotoxicity: Reversible Damage not only on Peripheral Nerves 421
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes 396
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 393
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 388
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 381
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 378
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 370
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings 364
Neuropatie periferiche da chemioterapia 357
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 351
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 341
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 332
Ion Channel and Transporter Involvement in Chemotherapy-Induced Peripheral Neurotoxicity 328
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 327
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 321
Guillain-Barré syndrome related to COVID-19 infection 321
3D Digital tools in human anatomy teaching from peer-to-peer tutoring to clinically oriented approaches: a single center experience. 320
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 314
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 308
Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review 305
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 305
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 295
Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)—a white paper 292
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 291
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 291
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 288
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 276
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 276
3D Digital tools in neuro-anatomy teaching: from peer-to-peer tutoring to clinically oriented approaches 274
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 269
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 265
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 265
Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue 261
Oxaliplatin-induced Peripheral Neurotoxicity: role of ion channels/transporters in axonal damage. 260
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 258
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 256
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin 255
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: A genome-wide study replication and meta-analysis 255
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 254
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 251
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 251
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 249
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 249
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer 249
Severe, reversible nelarabine-induced neuropathy and myelopathy 248
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 247
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 246
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 245
Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care—an international Delphi study 244
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools 241
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients 240
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 239
Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data 238
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 238
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 236
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNoms study 236
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 235
Histone deacetylases inhibitors: a new frontier for neuroprotection? 232
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 230
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 230
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 230
Guillain–Barré Syndrome Associated with COVID-19 229
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 228
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 228
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 226
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 220
A Longitudinal Study on Oxaliplatin Induced Peripheral Neuropathy – Incidence and Facts About the “Real Life” Population And Actual Dose 220
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 219
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 218
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 217
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 216
Neurophysiological examination of dorsal sural nerve 215
Chemotherapy-induced neuropathy 212
Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study 212
Neurofilament light chain serum levels as a possible paclitaxel-induced peripheral neurotoxicity biomarker: pilot and feasibility study. 211
In vivo study of Carfilzomib-Induced Neuropathy 211
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 210
When progressive dysphagia could be related to an “old friend” – a case report 208
Chemotherapy induced peripheral neurotoxicity: Six essential articles for effective future research 206
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 205
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 204
Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: Results from a prospective multicenter study 204
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin 202
Incidence, characteristics, and associations of oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: Results of a prospective, multicenter, international study. 202
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 201
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 199
Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial 199
Dorsal sural nerve conduction study in the assessment of oxaliplatin induced peripheral neuropathy 198
The significance of dorsal sural nerve recordings in early detecting oxaliplatin-induced peripheral neuropathy. 198
NERVE EXCITABILITY TESTING IN ANIMAL MODELS OF OXALIPLATIN INDUCED PERIPHERAL NEUROTOXICITY: ION CHANNEL DYSFUNCTION AS A POSSIBLE PATHOGENETIC MECHANISM. 196
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients 194
Totale 28.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.186
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.519 0 0 0 0 0 498 470 505 305 265 172 304
2021/20222.010 147 252 179 179 171 165 79 91 112 130 174 331
2022/20233.550 434 806 333 313 272 575 78 193 251 69 121 105
2023/20243.401 112 168 174 158 389 706 623 161 240 94 95 481
2024/20259.336 449 1.032 827 426 789 378 681 327 944 1.207 848 1.428
2025/202617.479 5.256 3.124 3.576 2.170 2.273 1.080 0 0 0 0 0 0
Totale 47.758